Stay updated on Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe history now shows the latest revision as v3.5.4, replacing v3.5.3. This reflects a small metadata update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision number was updated from v3.5.2 to v3.5.3, indicating a general platform/software revision rather than a change to the trial record details.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded last known status details and Poitiers University Hospital with date 2023-01 and verification; updated the revision to v3.5.2 and removed the previous v3.5.0.SummaryDifference0.9%

- Check73 days agoChange DetectedAdded revision v3.5.0 to the record history and removed v3.4.3.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision history shows an update from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check109 days agoChange DetectedNew revision entry v3.4.2 is added and v3.4.1 is removed in the study's record history. This reflects internal version tracking rather than substantive changes to trial information.SummaryDifference0.1%

Stay in the know with updates to Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.